Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX)

146 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 57,252,817 shares of 73,039,333 outstanding shares and own 78% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5,829,570 shares), CITADEL ADVISORS LLC (5,758,394 shares), Capital International Investors (5,247,646 shares), BlackRock Inc. (4,771,657 shares), FARALLON CAPITAL MANAGEMENT LLC (3,170,000 shares), TANG CAPITAL MANAGEMENT LLC (3,100,000 shares), VANGUARD GROUP INC (2,994,242 shares), Octagon Capital Advisors LP (2,391,114 shares), Redmile Group, LLC (2,164,126 shares), and GOLDMAN SACHS GROUP INC (1,459,131 shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.